Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing. [electronic resource]
Producer: 20180326Description: 36319-36330 p. digitalISSN:- 1949-2553
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Biomarkers
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- DNA Mutational Analysis
- Disease Models, Animal
- Gallbladder Neoplasms -- drug therapy
- High-Throughput Nucleotide Sequencing
- Humans
- MAP Kinase Signaling System -- drug effects
- Mice
- Molecular Targeted Therapy
- Mutation
- NF-kappa B -- metabolism
- Protein Kinase Inhibitors -- pharmacology
- Pyridones -- pharmacology
- Pyrimidinones -- pharmacology
- Signal Transduction -- drug effects
- Tumor Stem Cell Assay
- Wnt Signaling Pathway -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.